Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Nature Communications
|
March 29, 2024
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
Daming Zhou, Piyada Supasa, Chang Liu, et al.
Nature Communications
|
April 16, 2024
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection
Chang Liu, Raksha Das, Aiste Dijokaite-Guraliuc, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 19, 2024
Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition
Roi Asor, Anna Olerinyova, Sean A Burnap, et al.
Nature Communications
|
June 7, 2023
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
Manon Ragonnet-Cronin, Rungtiwa Nutalai, Jiandong Huo, et al.
Cell Host & Microbe
|
September 10, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
Jiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Cell Host & Microbe
|
June 26, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
Jiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Theranostics
|
January 6, 2022
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
Kuan-Ying A Huang, Daming Zhou, Tiong Kit Tan, et al.
Cell Reports. Medicine
|
May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Chang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
The Lancet. Infectious Diseases
|
November 25, 2023
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study
Xiaohong Fan, Xiahong Dai, Yun Ling, et al.
Cell Host & Microbe
|
December 18, 2021
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
Chang Liu, Daming Zhou, Rungtiwa Nutalai, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Nature Communications
|
March 29, 2024
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
Daming Zhou, Piyada Supasa, Chang Liu, et al.
Nature Communications
|
April 16, 2024
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection
Chang Liu, Raksha Das, Aiste Dijokaite-Guraliuc, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 19, 2024
Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition
Roi Asor, Anna Olerinyova, Sean A Burnap, et al.
Nature Communications
|
June 7, 2023
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
Manon Ragonnet-Cronin, Rungtiwa Nutalai, Jiandong Huo, et al.
Cell Host & Microbe
|
September 10, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
Jiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Cell Host & Microbe
|
June 26, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
Jiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Theranostics
|
January 6, 2022
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
Kuan-Ying A Huang, Daming Zhou, Tiong Kit Tan, et al.
Cell Reports. Medicine
|
May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Chang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
The Lancet. Infectious Diseases
|
November 25, 2023
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study
Xiaohong Fan, Xiahong Dai, Yun Ling, et al.
Cell Host & Microbe
|
December 18, 2021
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
Chang Liu, Daming Zhou, Rungtiwa Nutalai, et al.
Page
of 9